Dexmedetomidine inhibits fear memory consolidation via the astrocyte-specific Srebf1-Phgdh pathway in the prelimbic prefrontal cortex
Open Access
- 17 March 2026
- journal article
- Published by Elsevier in Cell Reports
- Vol. 45 (4) , 117125
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82071208)
- National Natural Science Foundation of China (82001421)
- Wuhan University (ZNJC202311)
This publication has 49 references indexed in Scilit:
- Presynaptic Adrenoceptors2024
- Effect of Dexmedetomidine on Posttraumatic Stress Disorder in Patients Undergoing Emergency Trauma SurgeryJAMA Network Open, 2023
- Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central α2A adrenoceptorBrain, Behavior, and Immunity, 2020
- Dexmedetomidine alleviates insulin resistance in hepatocytes by reducing endoplasmic reticulum stressEndocrine, 2019
- Reconsolidation/destabilization, extinction and forgetting of fear memory as therapeutic targets for PTSDPsychopharmacology, 2018
- Astrocyte lipid metabolism is critical for synapse development and function in vivoGlia, 2017
- Neuronal Activity-Induced Sterol Regulatory Element Binding Protein-1 (SREBP1) is Disrupted in Dysbindin-Null Mice—Potential Link to Cognitive Impairment in SchizophreniaMolecular Neurobiology, 2016
- Harnessing the trophic and modulatory potential of statins in a dopaminergic cell lineSynapse, 2015
- Association of Parkinson Disease Risk Loci With Mild Parkinsonian Signs in Older PersonsJAMA Neurology, 2014
- Neurotransmitter‐mediated calcium signalling in oligodendrocyte physiology and pathologyGlia, 2006